Artificial Intelligence. Illustration by designer Mopic
Experts from the Russian Venture Company (RVC) have developed a draft of the first national standard governing clinical trials of medical artificial intelligence systems in the Russian Federation, the company said.
The development of the first edition of the draft national standard was carried out for five months. The technical committee Artificial Intelligence and the Center for Diagnostics and Telemedicine worked on it.
It is assumed that the national standard will regulate critical aspects of AI in healthcare and its role in making medical decisions, the methodological basis of the clinical trials process, the procedure for conducting them, accuracy indicators, audit, and quality control of intelligent medical systems. Until October 2020, interested parties can make remarks, suggestions, and comments to the draft standard during the public discussion.